Balance better survival and disease progression with toxicity in metastatic colorectal cancer
Incremental improvements in survival and disease progression from additional chemotherapeutic agents must be balanced with the serious toxic effects of multidrug combinations in patients with metastatic colorectal cancer, a meta-analysis has concluded....
Want to read complete article? Please Sign in or Register.